|Day Low/High||38.16 / 38.62|
|52 Wk Low/High||27.88 / 40.97|
The trade for highly discretionary capital is the in-the-money, long call shooter expiring in January.
Blueprint unveiled new data from its ongoing Phase 1 study of avapritinib in advanced systemic mastocytosis at the 59th American Society of Hematology Annual Meeting.
These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.
The fundamentals are there, supported by earnings. Let's look at the charts.
Pfizer is reportedly planning to sell its consumer healthcare business in an auction next month
Treasury secretary says it's baked into the market, but is anyone really counting on it?
The Dow, the Nasdaq and the S&P 500 all reached new record highs even though drug stocks were under pressure following comments by President Trump.
Shares of Walmart jumped higher on Tuesday after the world's largest retailer updated fiscal 2019 forecasts and announced a new share buyback program.
Investors rolled into shares of Apple in September, according to TD Ameritrade, but took profits on shares of Bristol-Myers and Pfizer shares.
The Dow Jones Industrial Average hit a fresh intraday record earlier, but the rest of markets remained shaky after the latest inflation numbers called the Fed's plans into question.
The blue-chip index gets all the attention, but doesn't necessarily deserve it.
Jim Cramer weighs in on Tuesday's trending stocks.
U.S. stock futures were pointing to strong gains for Wall Street on Tuesday
The Dow Jones Industrial Average is looking at a strong open and possibly could cross the 22,000 milestone today.
Oil major swings to profit as crude prices recover